Last reviewed · How we verify
thyroid hormone replacement therapy
At a glance
| Generic name | thyroid hormone replacement therapy |
|---|---|
| Sponsor | Nabil Mahmoud Ismail Abdel-Aal |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism (PHASE2)
- Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
- Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism (NA)
- Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (PHASE2)
- Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography
- Thyroid Cancer in Surgical Treated Multinodular Goiter
- Thyroid Function and Structure in Klinefelter Syndrome
- Effect of Photobiomodulation Therapy in Patients With Hashimoto's Thyroiditis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: